Quarterly report pursuant to Section 13 or 15(d)

Supplemental Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details)

v3.22.2.2
Supplemental Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued consulting $ 229,661 $ 210,000
Accrued compensation 417,573 421,734
Deferred revenue 23,683 0
Accrued research and development 1,586,138 2,077,932
Accrued interest 0 968
Accrued other 32,671 5,127
Total accrued expenses and other current liabilities $ 2,289,726 $ 2,715,761